NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Azcuris

Azcuris

Private
SejongHealthcare & Life Scienceshttps://www.azcuris.com/

Last Round

Series B

Apr 30, 2026

Est. Valuation

$45.5M

Total Funding Raised

$7M

Company Overview

Azcuris is a biotechnology company that develops first-in-class, small-molecule therapeutics targeting protein-protein interactions to treat immune-mediated diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

drug discoverysmall-molecule therapeuticsprotein-protein interactionPPIAI drug discoveryin silico drug designde novo drug designmolecular dockingbiotechnologyimmune disease therapeuticspharma licensingtechbiodrug pipelinecomputational biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Azcuris Comparables

Compare Azcuris with similar companies based on industry and business-model similarity.

Azcuris comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eli Lilly and Company
76%
Galux
74%
Odyssey Therapeutics
69%

Azcuris Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BApr 30, 2026
VC RoundJun 1, 2021
Series AJul 1, 2020
SeedNov 1, 2018

Key People

Founding team and executive leadership

Young Ho Jeon

Chief Executive Officer

Executive Team

Ho Soon Kim

Chief Technology Officer

Executive Team

Azcuris Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2020

    $3.5M round raised

Azcuris Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Azcuris Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Azcuris's valuation, stock price, and market status.

Firmographic Details

HeadquartersSejong
Employee Range10
Year Founded2018
Last FundingApr 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.